Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
Latest Information Update: 04 Oct 2019
At a glance
- Drugs Rivoceranib (Primary) ; Cisplatin; Docetaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- 05 Oct 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 05 Oct 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 20 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.